News
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results